KYNB · Company research
Kyntra Bio, Inc. (KYNB): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
18records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| Kyntra Bio Inc. (KYNB) Rises 2.52% to $6.11, Testing the Upper Edge of Its Recent Range - Sector ETF Flow - https://www.dars.gov.et/ | Kyntra Bio Inc. (KYNB) Rises 2.52% to $6.11, Testing the Upper Edge of Its Recent Range - Sector ETF Flow https://www.dars.gov.et/ | View source ↗ | https://www.dars.gov.et/ | Oct 11, 2026 | neutral | 0 | 0.6 |
| Kyntra Bio Faces Nasdaq Delisting, Appeals Listing Decision - The Globe and Mail | Kyntra Bio Faces Nasdaq Delisting, Appeals Listing Decision The Globe and Mail | View source ↗ | The Globe and Mail | Oct 7, 2026 | neutral | 0 | 0.6 |
| A director receives 14,000 Kyntra Bio (KYNB) stock options with a $6.50 exercise price. - Stock Titan | A director receives 14,000 Kyntra Bio (KYNB) stock options with a $6.50 exercise price. Stock Titan | View source ↗ | Stock Titan | Oct 6, 2026 | neutral | 0 | 0.6 |
| Director Andrew E. Singer reports initial ownership information for Kyntra Bio (KYNB). - Stock Titan | Director Andrew E. Singer reports initial ownership information for Kyntra Bio (KYNB). Stock Titan | View source ↗ | Stock Titan | Oct 6, 2026 | neutral | 0 | 0.6 |
| Kyntra Bio Appoints Andrew E. Singer, MBA to its Board of Directors | Kyntra Bio announced the appointment of Andrew E. Singer, an experienced biotechnology finance executive with 25+ years in investment banking and corporate strategy, to its Board of Directors as an independent director and Audit Committee member effective October 1, 2026. Simultaneously, Maykin Ho stepped down after nearly eight years of service. Singer's appointment is expected to strengthen the company's financial position as it advances its rare disease and oncology pipeline. | View source ↗ | GlobeNewswire Inc. | Oct 1, 2026 | bullish | 1 | 1 |
| A director leaves after nearly eight years as Kyntra Bio adds a new board member - Stock Titan | A director leaves after nearly eight years as Kyntra Bio adds a new board member Stock Titan | View source ↗ | Stock Titan | Oct 1, 2026 | neutral | 0 | 0.6 |
| Kyntra Bio (KYNB) CEO reports RSU tax withholding, not a stock sale - Stock Titan | Kyntra Bio (KYNB) CEO reports RSU tax withholding, not a stock sale Stock Titan | View source ↗ | Stock Titan | Sep 9, 2026 | neutral | 0 | 0.6 |
| A drug company's CEO will present in New York Sept. 15. Kyntra Bio will webcast it. - Stock Titan | A drug company's CEO will present in New York Sept. 15. Kyntra Bio will webcast it. Stock Titan | View source ↗ | Stock Titan | Sep 2, 2026 | neutral | 0 | 0.6 |
| Kyntra Bio (KYNB) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance | Kyntra Bio (KYNB) Reports Q2 Loss, Lags Revenue Estimates Yahoo Finance | View source ↗ | Yahoo Finance | Aug 13, 2026 | neutral | 0 | 0.6 |
| KYNTRA BIO ($KYNB) Releases Q2 2026 Earnings - Quiver Quantitative | KYNTRA BIO ($KYNB) Releases Q2 2026 Earnings Quiver Quantitative | View source ↗ | Quiver Quantitative | Aug 13, 2026 | neutral | 0 | 0.6 |
| KYNB Forecast — Price Target — Prediction for 2027 - TradingView | KYNB Forecast — Price Target — Prediction for 2027 TradingView | View source ↗ | TradingView | Jun 26, 2026 | neutral | 0 | 0.6 |
| Kyntra Bio stock rises on roxadustat MDS trial data - Investing.com | Kyntra Bio stock rises on roxadustat MDS trial data Investing.com | View source ↗ | Investing.com | Jun 11, 2026 | neutral | 0 | 0.6 |
| Kyntra Bio (KYNB) Stock Forecast and Price Target 2026 - MarketBeat | Kyntra Bio (KYNB) Stock Forecast and Price Target 2026 MarketBeat | View source ↗ | MarketBeat | Jan 16, 2026 | neutral | 0 | 0.6 |
| Kyntra Bio, Inc. (KYNB) Stock Price, News, Quote & History - Yahoo! Finance Canada | Kyntra Bio, Inc. (KYNB) Stock Price, News, Quote & History Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Jan 10, 2026 | neutral | 0 | 0.6 |
| What is the current Price Target and Forecast for Kyntra Bio Inc (KYNB) - Zacks Investment Research | What is the current Price Target and Forecast for Kyntra Bio Inc (KYNB) Zacks Investment Research | View source ↗ | Zacks Investment Research | Jan 10, 2026 | neutral | 0 | 0.6 |
| symbol__ Stock Quote Price and Forecast - CNN | symbol__ Stock Quote Price and Forecast CNN | View source ↗ | CNN | Jan 10, 2026 | neutral | 0 | 0.6 |
| Kyntra Bio (Nasdaq:KYNB) - Stock Analysis - Simply Wall Street | Kyntra Bio (Nasdaq:KYNB) - Stock Analysis Simply Wall Street | View source ↗ | Simply Wall Street | Jan 9, 2026 | neutral | 0 | 0.6 |
| KYNB | Kyntra Bio Inc. Stock Overview (U.S.: Nasdaq) - Barron's | KYNB | Kyntra Bio Inc. Stock Overview (U.S.: Nasdaq) Barron's | View source ↗ | Barron's | Jan 8, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.